QCM
LLY icon

Qsemble Capital Management’s Eli Lilly LLY Stock Holding History

Qsemble Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.77M Buy
9,538
+8,530
+846% +$8.65M 0.67% 35
2025
Q4 		$1.08M Buy
+1,008
New +$964K 0.09% 266
2025
Q1 		– Sell
-452
Closed -$349K – 517
2024
Q4 		$349K Sell
452
-2,820
-86% -$2.33M 0.05% 319
2024
Q3 		$2.9M Buy
+3,272
New +$2.94M 0.53% 58
2023
Q4 		– Sell
-6,125
Closed -$3.29M – 423
2023
Q3 		$3.29M Buy
+6,125
New +$3.16M 0.61% 58

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Qsemble Capital Management's LLY Position: Q1 2026 in Review

Qsemble Capital Management increased its Eli Lilly (LLY) stake by 846% in Q1 2026, buying an estimated $8.65M and bringing the position to 9,538 shares worth $8.77M. The position accounts for 0.67% of the portfolio, ranked #35.

Qsemble Capital Management first reported a position in LLY in Q3 2023 and has held it in 5 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Qsemble Capital Management held 9,538 shares of Eli Lilly worth $8.77M as of Q1 2026.
  • Qsemble Capital Management bought 8,530 Eli Lilly shares in Q1 2026, an estimated $8.65M.
  • Eli Lilly made up 0.67% of Qsemble Capital Management's portfolio in Q1 2026, its #35 holding.
  • Qsemble Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 5 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Qsemble Capital Management's 13F filing for Q1 2026, filed 7 May 2026.